Quantcast
Last updated on April 17, 2014 at 14:37 EDT

Latest Cervarix Stories

2013-03-12 23:02:45

polyDNA urges military healthcare providers to recommend Gene-Eden-VIR, an HPV remedy, to infected service women Rochester, NY (PRWEB) March 12, 2013 polyDNA, a biotechnology company, has learned that "Studies indicate a high prevalence of risky sexual behaviors - including inconsistent condom use, multiple sexual partners, and binge drinking — that lead to unintended and unsafe sex" among female, military service members. The study was published in the Journal of Women's Health [1]....

2013-01-28 20:21:44

By the National Cancer Institute Editor's Note: The following article is part of the monthly Lifelines education and awareness print series that the National Cancer Institute provides to African American news and information outlets BETHESDA, Md., Jan. 28, 2013 /PRNewswire-USNewswire/ -- We can vaccinate our children against polio, against measles, against the flu. And more recently a vaccine has become available that lets parents give their children a new leg up against...

2012-10-14 23:20:18

ATLANTA, Oct. 15, 2012 /PRNewswire/ -- The human papillomavirus (HPV) vaccine known as Gardasil is not associated with an increase in pregnancy, sexually transmitted infections, or contraceptive counseling, according to a Kaiser Permanente study published online today in the journal Pediatrics. Since 2006, the Centers for Disease Control and Prevention has recommended that girls ages 11-12 receive three doses of the vaccine to protect them from HPV, which is transmitted through sexual...

2012-10-10 15:23:12

BLUE BELL, Pa., Oct. 10, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today clinical results indicating that its VGX-3100 therapeutic synthetic vaccine is capable of not only driving robust immune responses to antigens from high risk types of human papillomavirus (HPV) infection but that these immune responses displayed a powerful killing effect on cells changed by HPV into precancerous dysplasias. This desirable effect may ultimately contribute to the...

Should HPV Vaccines Be Given To Men?
2012-08-08 12:33:33

Connie K. Ho for redOrbit.com — Your Universe Online Color blindness. Menstrual cycle. Males and females differ in a number of areas when it comes to the human body, including vaccinations offered. A new study sparked a debate in the public health sphere when it examined whether the vaccination against human papilloma virus (HPV) should be given to males. To begin, researchers from the University of Southern California and University of California, Los Angeles (UCLA) David Geffen...

2012-07-04 06:20:25

LUSAKA, Zambia, July 4, 2012 /PRNewswire/ -- During a visit to the University Teaching Hospital in Lusaka today, President George W. Bush, Mrs. Laura Bush, First Lady of Zambia Dr. Christine Kaseba, Zambian Minister of Health Dr. J Kasonde and United States Ambassador to Zambia Mark Storella dedicated the African Center of Excellence for Women's Cancer Control. President Bush also announced the donation of a new electronic hub (e-Hub) at the Center of Excellence, on behalf of all Pink Ribbon...

2012-05-08 02:28:07

NEWARK, Del., May 8, 2012 /PRNewswire/ -- iBio, Inc. (NYSE AMEX: IBIO) today announced issuance of a US patent covering compositions of matter and methods of use of modified lichenase B polypeptides comprising the Company's iBioModulator(TM) platform. The new patent, which provides broad protection of the platform, is US Patent 8,173,408, entitled "Recombinant Carrier Molecule for Expression, Delivery and Purification of Target Polypeptides." (Logo:...

2012-04-03 02:27:54

PORTLAND, Ore., April 3, 2012 /PRNewswire/ -- Younger girls are more likely than adult women to report side effects after receiving Gardasil, the human papillomavirus vaccine. The side effects are non-serious and similar to those associated with other vaccines, according to a new study funded by the Centers for Disease Control and Prevention and published in the Journal of Women's Health. As part of an ongoing study and evaluation of this relatively new vaccine, researchers surveyed 899...

2012-02-22 08:00:00

MERIDEN, Conn., Feb. 22, 2012 /PRNewswire/ -- Protein Sciences Corporation ("Protein Sciences") announced today that it has granted Merck, through a subsidiary, a non-exclusive license to Protein Sciences' proprietary expresSF+® serum-free insect cell line (SF+) and related technology (collectively, PS Technology) to conduct vaccine research. In addition, Protein Sciences has granted Merck an exclusive license to use PS Technology for commercial production of an undisclosed vaccine...

2012-01-18 08:00:00

The publication of the startling results of a Canadian study involving the effectiveness of the Human Papillomavirus (HPV) vaccine against cervical cancer demonstrate that vaccine policy and evidence-based medicine are at odds. Lucija Tomljenovic, PhD and Christopher A. Shaw, PhD of the University of British Columbia´s evidence-based study was recently published in the Annals of Medicine, a highly-ranked peer reviewed medical journal....